Background: Women diagnosed with
Introduction
The human immunodeficiency virus (HIV) is a lentivirus (a subgroup of retrovirus) that causes HIV infection and over time acquired immunodeficiency syndrome (AIDS) [4] [5] . AIDS is a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive. Without treatment, average survival time after infection with HIV is estimated to be 9 to 11 years, depending on the HIV subtype [6] . Infection with HIV occurs by the transfer of blood, semen, vaginal fluid, pre-ejaculate, or breast milk. Within these bodily fluids, HIV is present as both free virus particles and virus within infected immune cells.
HIV infects vital cells in the human immune system such as helper T cells (specifically CD4 + T cells), macrophages, and dendritic cells [7] . HIV infection leads to low levels of CD4+ T cells through a number of mechanisms, including pyroptosis of abortively infected T cells [8] , apoptosis of uninfected bystander cells [9] , direct viral killing of infected cells, and killing of infected CD4 + T cells by CD8 cytotoxic lymphocytes that recognize infected cells [10] . When CD4 + T cell numbers decline below a critical level, cell-mediated immunity is lost, and the body becomes progressively more susceptible to opportunistic infections. 
Objectives

Materials and Method
A retrospective study of detection of HIV positive among all the antenatal patients attending OPD and including the patients coming in Emergency services and delivered in Department of Obstetrics and Gynecology at MGMMC & M. Y. Hospital, Indore, Madhya Pradesh (India) from Jan. 2009 to Dec. 2015 were included in the study. They were screened for HIV status and further management for all HIV positive patients.
Results
The incidence of HIV has dropped consistently i.e. from Deliveries. According to recent guideline, Elective LSCS is not recommended. It is evident from the data in Table 4 and Figure 4 that mother to child transmission was nearly 4 cases in LSCS and nearly 3 cases in VAGINAL deliveries in past 7 years. In Table 3 and In accordance to NACO and PPTCT, Tablet NVP 200 mg should be given 2 hours before planned delivery or at onset of labour. The newborn should be given nevirapine suspension. Now it has been changed to TLE Regimen to mother for atleast 24
weeks & NVP to baby. According to recent guideline, Elective LSCS is not recommended. Mixed feeding should be avoided. Only Breast feeding should be continued in developing countries. None of the babies were found to HIV reactive at the end previous 2 years irrespective of mode of delivery as in Table 5 and Figure 5 . Certified  2009  38  33  0  5  0  2010  38  35  0  3  3  2011  50  45  1  4  6  2012  60  42  3  5  2  2013  46  42  1  3  0  2014  58  53  2  3  0  2015  46  48  2  6  0 
Observations
It was because of novel approach of NACP and PPTCT counselling enabling the antenatal women to be diagnosed earlier. In 2009 only 29 patients were found to be reactive w.r.t 2015 there were 15 patients who were reactive at our institute. Most of the patients are getting delivered at a tertiary care center (MYH), thus ensuring the Prophylactic and Postnatal care of the mother and baby.
Discussion
The risk of vertical transmission of HIV from mother to baby ranges from 7% -40%. Maternal HIV transmission is the primary means by which infant become infected. Hence prevention of maternal HIV transmission is of paramount importance. The Indian Council of Medical Research initiated a serosurveillance among high risk group to ascertain the magnitude of HIV infection at regular intervals so as to know the trends and patterns of the disease in the community which would facilitate proper prevention and management.
The study was conducted on all the HIV positive antenatal patients attending OPD and including the patients coming in Emergency services and delivered in Department of Obstetrics and Gynecology at MGMMC & M.Y. Hospital, Indore, Madhya Pradesh (India) from Jan 2006 to Jan 2016. During this study period, there were 338 deliveries in these 7 years from Jan 2009 to Dec 2015. The most common route of infection is sexual transmission more commonly through male to female w.r.t female to male. So the fetus becomes the innocent bearer of the disease. These children were called at 6weeks, 6 months and 18 months for follow up.
The PPTCT program has significantly improvised its ANC OPD burden from 6422 in 2006, 9138 in 2010 to 9935 in 2015 among those for HIV screening as in Table 1 . Out of them total of 2122 were tested in 2006 and 6099 in 2010 and 13,274 in 2015. It implies the efficacy of effective implementation of PPTCT program. From the data obtained, the incidence of HIV has dropped consistently i.e. from 0.5% to 0.15% i.e. from 2006 to 2015. Earlier LSCS was promoted for delivery in case of HIV positive patients but Now-a-days Elective LSCS has been implemented thus decreasing rate of transmission.
According to Kesho Bora study, Infants of mothers with undetectable virus levels after being given Triple ARVs at time of delivery has only 2.7% risk of HIV infection at the end of one year. So initiation of ARVs early in pregnancy and to all women who require ART irrespective of CD4 count as per 2013 guidelines significantly eliminate risk of Mother to Child HIV Transmission.
There were 338 deliveries from 2009 to 2015, 298 babies were found to be alive healthy and 11 were certified.29 went to nursery and 9 were with Intrauterine fetal demise.
Conclusions
 In accordance to NACO and PPTCT, Tablet NVP 200 mg should be given 2 hours before planned delivery or at onset of labour. The newborn should be given Nevirapine suspension. Now, it has been changed to TLE Regimen to mother for at least 24 weeks & NVP to baby.  For preventing MTCT, Triple ART should be started irrespective of CD4 count and clinical stage. The 2010 revised PMTCT guidelines refer to the following two key approaches: 1) Lifelong ART for HIV-infected women in need of treatment for their own health, which is also safe and effective in reducing mother to child transmission of HIV (MTCT).
2) Short-term ARV prophylaxis to prevent MTCT during pregnancy, delivery and breastfeeding for HIV-infected women not in need of treatment. pregnant women in need of treatment for their own health should start ART irrespective of gestational age and should continue with it throughout pregnancy, delivery, during breastfeeding and thereafter.  In both sets of guidelines, the timing of ART initiation for HIV-positive pregnant women is the same as for non-pregnant women, i.e. as soon as the eligibility criteria are met. Women are the same as for non-pregnant women, i.e. as soon as the eligibility criteria are met [11] .
• Following guidelines can prevent Parent to Child transmission.
Category
Treatment duration
All pregnant women presenting late in labour and breast feeding Triple ART for 24 weeks NVP to baby when mother on ART since diagnosed For 6 weeks NVP to baby when mother was started on ART in late pregnancy, during or after delivery For 12 weeks
Infants of breast feeding babies not exclusive feeding Give NVP
